Amir G. Masri
Research Subjects
Amir G. Masri has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Aleksander Vladimirovich Bazhin
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies
3 shared publications - Olga Yu. Panina
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
3 shared publications - Alexey Vladimirovich Petraikin
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies
2 shared publications - Anna N. Khoruzhaya
Moscow Center for Diagnostics and Telemedicine
2 shared publications - Anton Vyacheslavovich Vladzymyrskyy
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, 127051 Moscow, Russia
2 shared publications - Aslanbek Midaev
Imed Clinic, Grozny, Chechen Republic, Russia
2 shared publications
Latest Publications
- Open Access
- 8 January 2026
- Published by ECO-Vector LLC (Publications) in Journal of Clinical Practice
- Vol. 17 (1) , 131-140
Atrioesophageal fistula after radiofrequency catheter ablation for atrial fibrillation: clinical case
BACKGROUND: Atrioesophageal fistula is a rare complication following radiofrequency catheter ablation for atrial fibrillation and is associated with high mortality. Clinical manifestations of atrioesophageal fistula are nonspecific and may include fever, neurological symptoms, and sepsis, which complicates timely diagnosis. A literature search was conducted in international databases PubMed, Google Scholar and eLibrary for the last five years (2019–2024) using the keywords “atrioesophageal fistula” and “complications of radiofrequency catheter ablation.” Thirty articles were selected for review. CLINICAL CASE DESCRIPTION: The aim of this publication is to present a rare case of atrioesophageal fistula development after radiofrequency catheter ablation in a 53-year-old female patient. The features of the clinical course, diagnostic challenges, as well as possible approaches to early recognition, prevention, and treatment of this complication were analyzed. CONCLUSION: Even when diagnosed early, atrioesophageal fistula carries an exceedingly poor prognosis. This underscores the critical need for sustained clinical vigilance, improved prevention strategies, and the establishment of standardized management guidelines for suspected cases of this lethal complication.
- 8 January 2026
- Published by ECO-Vector LLC (Publications) in Journal of Clinical Practice
- Vol. 17 (1) , 131-140
Open AccessAtrioesophageal fistula after radiofrequency catheter ablation for atrial fibrillation: clinical case
BACKGROUND: Atrioesophageal fistula is a rare complication following radiofrequency catheter ablation for atrial fibrillation and is associated with high mortality. Clinical manifestations of atrioesophageal fistula are nonspecific and may include fever, neurological symptoms, and sepsis, which complicates timely diagnosis. A literature search was conducted in international databases PubMed, Google Scholar and eLibrary for the last five years (2019–2024) using the keywords “atrioesophageal fistula” and “complications of radiofrequency catheter ablation.” Thirty articles were selected for review. CLINICAL CASE DESCRIPTION: The aim of this publication is to present a rare case of atrioesophageal fistula development after radiofrequency catheter ablation in a 53-year-old female patient. The features of the clinical course, diagnostic challenges, as well as possible approaches to early recognition, prevention, and treatment of this complication were analyzed. CONCLUSION: Even when diagnosed early, atrioesophageal fistula carries an exceedingly poor prognosis. This underscores the critical need for sustained clinical vigilance, improved prevention strategies, and the establishment of standardized management guidelines for suspected cases of this lethal complication.
- Open Access
- 1 June 2021
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 79, 13-19
Chest MRI of patients with COVID-19
- 1 June 2021
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 79, 13-19
Open AccessChest MRI of patients with COVID-19
- Open Access
- 30 December 2020
- Published by ECO-Vector LLC in Digital Diagnostics
- Vol. 1 (1) , 61-68
Chest MRI of a pregnant woman with COVID-19 pneumonia
This paper presents a clinical case of a 39-year-old pregnant woman with respiratory signs of the novel coronavirus Covid-19 infection. Chest MRI showed bilateral lesions in basal segments. The PCR test was positive. A lung condition was assessed without loss of significant diagnostic information. Besides that, the absence of exposure to ionizing radiation allowed to avoid a high loading dose on the patient and the fetus. This case reveals potential opportunities of MRI in the diagnosis of pulmonary pathology without exposure to ionizing radiation, especially in patient risk groups (children, pregnant women, etc.).
- 30 December 2020
- Published by ECO-Vector LLC in Digital Diagnostics
- Vol. 1 (1) , 61-68
Open AccessChest MRI of a pregnant woman with COVID-19 pneumonia
This paper presents a clinical case of a 39-year-old pregnant woman with respiratory signs of the novel coronavirus Covid-19 infection. Chest MRI showed bilateral lesions in basal segments. The PCR test was positive. A lung condition was assessed without loss of significant diagnostic information. Besides that, the absence of exposure to ionizing radiation allowed to avoid a high loading dose on the patient and the fetus. This case reveals potential opportunities of MRI in the diagnosis of pulmonary pathology without exposure to ionizing radiation, especially in patient risk groups (children, pregnant women, etc.).
- Open Access
Chest MRI of patients with COVID-19: a retrospective case study
During the pandemic of COVID-19, computed tomography showed its effectiveness in diagnosis of coronavirus infection. However, ionizing radiation during CT studies causes concern for patients who require dynamic observation, as well as for examination of children and young people. For this retrospective study, we included 15 suspected for COVID-19 patients who were hospitalized in April 2020, Russia. There were 4 adults with positive polymerase chain reaction (PCR) test for COVID-19. All patients underwent MRI examinations using MR-LUND PROTOCOL: Single-shot Fast Spin Echo (SSFSE), LAVA 3D and IDEAL 3D, EPI diffusion-weighted imaging (DWI) and Fast Spin Echo (FSE) T2WI without using respiratory or any other trigger. 3 patients also had CT scan performed. In 5 (33,3%) patients, detected lesioins were visualized on T2WI and DWI simultaneously. At the same time, 4 (26.7%) patients revealed lung tissue changes only on T2WI (P(McNemar)= 0,125, OR= 0,00 (95%), kappa=0,500). Pulmonary changes on MRI were also analyzed depending on their localization. In those patients who had CT scan, the changes were comparable to MRI. MRI of the lungs can detect features of viral pneumonia and assess severity of lung damage. The method can be used to diagnose COVID-19. These data may be applicable for interpreting other studies, such as thoracic spine MRI, detecting signs of viral pneumonia of asymptomatic patients. The current study was limited by a small sample size and absence of chest CT scans of all patients.
Open AccessChest MRI of patients with COVID-19: a retrospective case study
During the pandemic of COVID-19, computed tomography showed its effectiveness in diagnosis of coronavirus infection. However, ionizing radiation during CT studies causes concern for patients who require dynamic observation, as well as for examination of children and young people. For this retrospective study, we included 15 suspected for COVID-19 patients who were hospitalized in April 2020, Russia. There were 4 adults with positive polymerase chain reaction (PCR) test for COVID-19. All patients underwent MRI examinations using MR-LUND PROTOCOL: Single-shot Fast Spin Echo (SSFSE), LAVA 3D and IDEAL 3D, EPI diffusion-weighted imaging (DWI) and Fast Spin Echo (FSE) T2WI without using respiratory or any other trigger. 3 patients also had CT scan performed. In 5 (33,3%) patients, detected lesioins were visualized on T2WI and DWI simultaneously. At the same time, 4 (26.7%) patients revealed lung tissue changes only on T2WI (P(McNemar)= 0,125, OR= 0,00 (95%), kappa=0,500). Pulmonary changes on MRI were also analyzed depending on their localization. In those patients who had CT scan, the changes were comparable to MRI. MRI of the lungs can detect features of viral pneumonia and assess severity of lung damage. The method can be used to diagnose COVID-19. These data may be applicable for interpreting other studies, such as thoracic spine MRI, detecting signs of viral pneumonia of asymptomatic patients. The current study was limited by a small sample size and absence of chest CT scans of all patients.